(Q33746887)

29 July 2017

title

The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities (English)

1 reference

adaptive radiation therapy

29 July 2017

main subject

0 references

hepatocellular carcinoma

1 reference

Jenny Y Que

1

1 reference

29 July 2017

Li-Ching Lin

2

1 reference

29 July 2017

Kuei-Li Lin

3

1 reference

29 July 2017

Chia-Hui Lin

4

1 reference

29 July 2017

Yu-Wei Lin

5

1 reference

29 July 2017

Ching-Chieh Yang

6

1 reference

29 July 2017

publication date

28 May 2014

1 reference

29 July 2017

1 reference

29 July 2017

volume

9

1 reference

29 July 2017

page(s)

120

1 reference

Outcomes of hepatic resection for huge hepatocellular carcinoma (≥ 10 cm in diameter).

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Stereotactic body radiation therapy: the report of AAPM Task Group 101.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Radiation-associated liver injury.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Clinical accuracy of the respiratory tumor tracking system of the cyberknife: assessment by analysis of log files

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Radiotherapy for hepatocellular carcinoma: an overview.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

CyberKnife robotic arm stereotactic radiosurgery

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Advances in image-guided radiation therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Radiation therapy for hepatocellular carcinoma: from palliation to cure

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Dose-response relationship in local radiotherapy for hepatocellular carcinoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Outcome after curative resection for a huge (>or=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-120

Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-120

Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-120

Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-120

Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-120

Spatio-temporal evolution of female lung cancer mortality in a region of Spain, is it worth taking migration into account?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-120

Local radiotherapy for patients with unresectable hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-120

Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Pilot study of stereotactic body radiotherapy for huge hepatocellular carcinoma unsuitable for other therapies.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055213

Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization

30 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-120

Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1748-717X-9-120

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization

21 January 2018

1 reference

12 December 2020

Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies

1 reference

12 December 2020

Stereotactic radiotherapy of primary liver cancer and hepatic metastases

1 reference

12 December 2020

Prognosis and results after resection of very large (>or=10 cm) hepatocellular carcinoma

1 reference

12 December 2020

Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection

1 reference

12 December 2020

Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

1 reference

12 December 2020

Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis

1 reference

12 December 2020

Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases

1 reference

12 December 2020

Stereotactic body radiation therapy in recurrent hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1186/1748-717X-9-120

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference